Treating amyotrophic lateral sclerosis with a bone marrow derived mesenchymal stem cell extracellular vesicles - A case report

Amyotrophic Lateral Sclerosis (ALS) is a terminal neurodegenerative disease with only few minimally effective treatment options. This study treats patient Spinal ALS Bone Marrow Derived Mesenchymal Stem Cell Extracellular Vesicles (BM-MSCEVs) to slow or stop the progress of disease. After 2 months and 4 treatments, demonstrated improvement in functional scores most physical exam findings. BM-MSCEVs demonstrate ability effectively treat this open door for future studies.